Promomed (PRMD) Debt/EBITDA MSFO (year values) |
|||||||
2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.88 | 1.52 | 2.07 | 2.07 | |||
Changes by years, y/y, % | +73% | +36% | +53.6% |
Promomed. Debt/EBITDA
Promomed. Debt/EBITDA, changes, %
Promomed (PRMD) Debt/EBITDA MSFO (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | LTM ? | |||
Debt/EBITDA | 2.07 | 2.24 | 2.07 | 0.00 | 0.00 | 2.07 | ||
Changes by years, y/y, % | -100% | |||||||
Changes by quarters, q/q, % | +8% | -8% | -100% |